BioDesign Lab

The BioDesign approach to healthcare innovation was introduced in 2000 at Stanford University wIth a mission to train leaders in biomedical technology innovation. This framework guides innovators through the 3 key stages of identification, invention, and implementation. The process focuses first and foremost on screening and validating clinical needs, then developing and prototyping methods to address these needs, and finally the implementation and integration of novel healthcare solutions. This human-centered approach is grounded by a continuous assessment of health care value by incorporating factors like regulations, reimbursement, informatics, patient experience, and the other elements crucial to modern healthcare delivery. The Ochsner BioDesign Lab was founded to apply this approach to our community's shared and unique healthcare needs here in the Gulf South.

Augustin, D.A., C.A. Yock, J. Wall, L. Lucian, T. Krummel, J.B. Pietzsch, and D.E. Azagury, Stanford's Biodesign Innovation program: Teaching opportunities for value-driven innovation in surgery. Surgery, 2020. 167(3): p. 535-539.

Zenios, S., P. Yock, and J. Makower, Biodesign: The Process of Innovating New Medical Technologies. Cambridge University Press. 2010.